from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv1199c/-

LFCtreatmentdescriptionclass of inhibitor

0.173

Amikacinug/mL Amikacintranslation

0.170

Cap5-10ug/mL Capreomycintranslation

-0.165

Rox10-50 ug/mL Roxithromycintranslation

-0.240

SM2-5 ug/mL Streptomycintranslation

0.450

Tet5-10 ug/mL Tetracyclinetranslation

0.400

Rif0.2-5ug/mL Rifampicintranscription

0.072

Rifp0.1-0.5ug/mL Rifapentinetranscription

-1.077

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

1.088

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

-0.295

CPZ10-50 ug/mL Chlorpromazinerespiration

-1.619

Clofazimine10-13 ug/mL Clofaziminerespiration

-0.570

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

1.861

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

0.149

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

-0.148

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

-0.725

Econazole10-24 ug/mL Econazole (azole drug)respiration

-0.748

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

-0.134

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

0.588

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

-0.112

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

-0.825

KCN5-20 ug/mL Potassium cyaniderespiration

-0.202

NaN30.2-2 mM Sodium aziderespiration

0.310

Nigericin50 uM Nigericinrespiration

-0.217

TRC10-150 ug/mL Triclosanrespiration

-0.154

TRZ10-25 ug/mL Thioridazinerespiration

1.157

Valinomycin0.5-10 uM Valinomycinrespiration

-0.510

ZnSO42 mM ZnSO4respiration

-0.243

menadione6-10 ug/mL Menadionerespiration

0.149

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

0.134

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

0.858

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

0.040

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

0.020

NRP_1Non-replicating persistence stage 1dosRassociated

0.397

Amp0.2mg/mL AmpicillincellWall

0.458

Cephalexin20-100 ug/mL CephalexincellWall

0.003

Cerulenin0.32-5 ug/mL CerulenincellWall

0.545

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

0.637

EMB10-20 ug/mL EthambutolcellWall

-0.022

Eta12-40 ug/mL EthionamidecellWall

-0.290

INH0.2-0.4 ug/mL IsoniazidcellWall

0.147

TLM0.1-0.2 mg/mL ThiolactomycincellWall

0.501

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.831

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.892

BZA0.12 mg/mL BenzamidearomaticAmides

-0.539

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

-0.805

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

-0.202

H2O24 mM hydrogen peroxideDNAdamaging

0.601

Levo10 ug/mL LevofloxacinDNAdamaging

-0.690

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

-0.702

Novobiocin10 ug/mL NovobiocinDNAdamaging

0.719

Oflox5-10 ug/mL OfloxacinDNAdamaging

-0.540

UVUV-irradiationDNAdamaging

0.451

ARP41-4 ug/mL Antitubercular compound ARP4?

0.509

Antimycin12.5-50 ug/mL Antimycin A?

0.652

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

-0.866

PA_110-50 ug/mL Antitubercular compound PA-1?

0.451

PA_2110-50 ug/mL Antitubercular compound PA-21?

0.957

PA8240.2-2 ug/mL PA-824?

2.043

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

0.610

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

0.993

Verapamil50 uM Verapamil?

0.367

mercaptoethanol2 mM 2-Mercaptoethanol?

0.974

methoxatin10-20 ug/mL Methoxatin?